Aspirin and statin use and the subsequent development of depression in men and women: Results from a longitudinal population-based study

Journal of Affective Disorders

Volumn 182, Issue , 2015, Pages 126-131

  Glaus, Jennifer ^a,b   Vandeleur, Caroline L ^a   Lasserre, Aurélie M ^a   Strippoli, Marie Pierre F ^a   Castelao, Enrique ^a   Gholam Rezaee, Mehdi ^a   Waeber, Gérard ^a   Aubry, Jean Michel ^b   Vollenweider, Peter ^a   Preisig, Martin ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Aspirin; Inflammation; Longitudinal study; Major depressive disorder; Population based study; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; DSM-IV; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; SMOKING; URBAN AREA; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; SWITZERLAND;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SWITZERLAND;

EID: 84929335255     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.03.044     Document Type: Article

References (39)

1. O.P. Almeida, H. Alfonso, K. Jamrozik, G.J. Hankey, and L. Flicker Aspirin use, depression, and cognitive impairment in later life: the health in men study J. Am. Geriatr. Soc. 58 2010 990 992
2. O.P. Almeida, L. Flicker, B.B. Yeap, H. Alfonso, K. McCaul, and G.J. Hankey Aspirin decreases the risk of depression in older men with high plasma homocysteine Transl. Psychiatry 2 2012 e151
3. C. Antithrombotic Trialists, C. Baigent, L. Blackwell, R. Collins, J. Emberson, J. Godwin, R. Peto, J. Buring, C. Hennekens, P. Kearney, T. Meade, C. Patrono, M.C. Roncaglioni, and A. Zanchetti Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
4. A.S. Antonopoulos, M. Margaritis, R. Lee, K. Channon, and C. Antoniades Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials Curr. Pharm. Des. 18 2012 1519 1530
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders Text Revision 4th ed. 2000 American Psychiatric Association Arlington, VA
6. B.T. Baune, M. Stuart, A. Gilmour, H. Wersching, V. Arolt, and K. Berger Moderators of the relationship between depression and cardiovascular disorders: a systematic review Gen. Hosp. Psychiatry 34 2012 478 492
7. M. Berk, O. Dean, H. Drexhage, J.J. McNeil, S. Moylan, A. O'Neil, C.G. Davey, L. Sanna, and M. Maes Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness BMC Med. 11 2013 74
8. A. Berney, M. Preisig, M.L. Matthey, F. Ferrero, and B.T. Fenton Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of alcohol and drug diagnoses Drug Alcohol Depend. 65 2002 149 158
9. D.R. Cox Regression models and life tables. J.R. Stat. Soc. Series B 20 1972 187 220
10. J. Endicott, and R.L. Spitzer A diagnostic interview: the schedule for affective disorders and schizophrenia Arch. Gen. Psychiatry 35 1978 837 844
11. L. Feng, K.B. Yap, E.H. Kua, and T.P. Ng Statin use and depressive symptoms in a prospective study of community-living older persons Pharmacoepidemiol. Drug Saf. 19 2010 942 948
12. M. Firmann, V. Mayor, P.M. Vidal, M. Bochud, A. Pecoud, D. Hayoz, F. Paccaud, M. Preisig, K.S. Song, X. Yuan, T.M. Danoff, H.A. Stirnadel, D. Waterworth, V. Mooser, G. Waeber, and P. Vollenweider The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome BMC Cardiovasc. Disord. 8 2008 6
13. J. Glaus, C. Vandeleur, M. Gholam-Rezaee, E. Castelao, M. Perrin, S. Rothen, P. Bovet, P. Marques-Vidal, R. von Kanel, K. Merikangas, V. Mooser, D.M. Waterworth, G. Waeber, P. Vollenweider, and M. Preisig Atypical depression and alcohol misuse are related to the cardiovascular risk in the general population Acta Psychiatr. Scand. 128 2013 282 293
14. Hollingshead, A.B., 1975. Four factor Index of Social Status, New Heaven, CT.
15. M. Leboyer, B. Barbe, P. Gorwood, M. Teherani, J.F. Allilaire, M. Preisig, M.L. Matthey, V. Poyetton, and F. Ferrero Interview Diagnostique pour les Etudes Génétiques [Diagnostic Interview for Genetic Studies] 1995 INSERM Paris
16. M. Leboyer, W. Maier, M. Teherani, D. Lichtermann, T. D'Amato, P. Franke, J.P. Lepine, J. Minges, and P. McGuffin The reliability of the SADS-LA in a family study setting Eur. Arch. Psychiatry Clin. Neurosci. 241 1991 165 169
17. A.J. Morin, G. Moullec, C. Maiano, L. Layet, J.L. Just, and G. Ninot Psychometric properties of the Center for Epidemiologic Studies Depression Scale (CES-D) in French clinical and nonclinical adults Rev. Epidemiol. Sante Publique 59 2011 327 340
18. J.K. Myers, and M.M. Weissman Use of a self-report symptom scale to detect depression in a community sample Am. J. Psychiatry 137 1980 1081 1084
19. H. Nabi, M. Bochud, J. Glaus, A.M. Lasserre, G. Waeber, P. Vollenweider, and M. Preisig Association of serum homocysteine with major depressive disorder: results from a large population-based study Psychoneuroendocrinology 38 2013 2309 2318
20. J.I. Nurnberger Jr., M.C. Blehar, C.A. Kaufmann, C. York-Cooler, S.G. Simpson, J. Harkavy-Friedman, J.B. Severe, D. Malaspina, and T. Reich Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative Arch. Gen. Psychiatry 51 1994 849 859
21. C. Otte, S. Zhao, and M.A. Whooley Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the Heart and Soul Study J. Clin. Psychiatry 73 2012 610 615
22. A.K. Parsaik, B. Singh, M.H. Murad, K. Singh, S.S. Mascarenhas, M.D. Williams, M.I. Lapid, J.W. Richardson, C.P. West, and T.A. Rummans Statins use and risk of depression: a systematic review and meta-analysis J. Affect. Disord. 160 2014 62 67
23. J.A. Pasco, F.N. Jacka, L.J. Williams, M.J. Henry, G.C. Nicholson, M.A. Kotowicz, and M. Berk Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression Psychother. Psychosom. 79 2010 323 325
24. B.W. Penninx, Y. Milaneschi, F. Lamers, and N. Vogelzangs Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile BMC Med. 11 2013 129
25. M. Preisig, B.T. Fenton, M.L. Matthey, A. Berney, and F. Ferrero Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version Eur. Arch. Psychiatry Clin. Neurosci. 249 1999 174 179
26. M. Preisig, G. Waeber, P. Vollenweider, P. Bovet, S. Rothen, C. Vandeleur, P. Guex, L. Middleton, D. Waterworth, V. Mooser, F. Tozzi, and P. Muglia The PsyCoLaus study: methodology and characteristics of the sample of a population-based survey on psychiatric disorders and their association with genetic and cardiovascular risk factors BMC Psychiatry 9 2009 9
27. L.S. Radloff The CES-D scale: a self-report depression scale for research in the general population Appl. Psychol. Meas. 1 1977 385 401
28. C. Redlich, M. Berk, L.J. Williams, J. Sundquist, K. Sundquist, and X. Li Statin use and risk of depression: a Swedish national cohort study BMC Psychiatry 14 2014 348
29. R.E. Roberts, and S.W. Vernon The Center for Epidemiologic Studies Depression Scale: its use in a community sample Am. J. Psychiatry 140 1983 41 46
30. A. Rougemont-Buecking, S. Rothen, N. Jeanpretre, Y. Lustenberger, C.L. Vandeleur, F. Ferrero, and M. Preisig Inter-informant agreement on diagnoses and prevalence estimates of anxiety disorders: direct interview versus family history method Psychiatry Res. 157 2008 211 223
31. D. Rubin Multiple Imputation for Non-response in Surveys 1987 Wiley New York
32. J.L. Schafer Analysis of Incomplete Multivariate Data 1997 Chapman and Hall New York
33. L. Stafford, and M. Berk The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? J. Clin. Psychiatry 72 2011 1229 1235
34. J.A. Sterne, I.R. White, J.B. Carlin, M. Spratt, P. Royston, M.G. Kenward, A.M. Wood, and J.R. Carpenter Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls BMJ 338 2009 b2393
35. J.L. Thomas, G.N. Jones, I.C. Scarinci, D.J. Mehan, and P.J. Brantley The utility of the CES-D as a depression screening measure among low-income women attending primary care clinics. The Center for Epidemiologic Studies-Depression Int. J. Psychiatry Med. 31 2001 25 40
36. J. Vaucher, P. Marques-Vidal, G. Waeber, and P. Vollenweider Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention: a population-based study (CoLaus Study) Cytokine 66 2014 95 100
37. A. While, and L. Keen The effects of statins on mood: a review of the literature Eur. J. Cardiovasc. Nurs. 11 2012 85 96
38. I.R. White, P. Royston, and A.M. Wood Multiple imputation using chained equations: issues and guidance for practice Stat. Med. 30 2011 377 399
39. Y. Young-Xu, K.A. Chan, J.K. Liao, S. Ravid, and C.M. Blatt Long-term statin use and psychological well-being J. Am. Coll. Cardiol. 42 2003 690 697